Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Zydus Lifesciences Ltd (ZYDU)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
948.00 -3.25    -0.34%
26/04 - Closed. Currency in INR ( Disclaimer )
  • Volume: 697,084
  • Bid/Ask: 947.85 / 948.00
  • Day's Range: 944.50 - 958.65
Type:  Equity
Market:  India
ISIN:  INE010B01027 
S/N:  ZYDUSLIFE
Zydus Lifesciences 948.00 -3.25 -0.34%

NS:ZYDU Financials

 
This summary provides an overview of the most significant critical numbers from each of the Cadila Healthcare financial reports, including theZydus Lifesciences Ltd income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NS:ZYDU financials over time via breakdowns of their annual reports.

Zydus Lifesciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported revenue was INR 44,228 million compared to INR 40,499 million a year ago. Net income was INR 8,007 million compared to INR 5,225 million a year ago. Basic earnings per share from continuing operations was INR 7.92 compared to INR 5.1 a year ago. Diluted earnings per share from continuing operations was INR 7.92 compared to INR 5.1 a year ago. Basic earnings per share was INR 7.91 compared to INR 5.15 a year ago. Diluted earnings per share was INR 7.91 compared to INR 5.15 a year ago.For the six months, revenue was INR 95,984 million compared to INR 80,801 million a year ago. Net income was INR 18,876 million compared to INR 10,408 million a year ago. Basic earnings per share from continuing operations was INR 18.67 compared to INR 10.24 a year ago. Diluted earnings per share from continuing operations was INR 18.67 compared to INR 10.24 a year ago. Basic earnings per share was INR 18.65 compared to INR 10.21 a year ago. Diluted earnings per share was INR 18.65 compared to INR 10.21 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ZYDU Income Statement & Profits

Gross margin TTM 65.97%
Operating margin TTM 22.36%
Net Profit margin TTM 15.63%
Return on Investment TTM 16.48%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 45052 43688 51396 46677
Gross Profit 30367 28950 34652 28111
Operating Income 8870 8797 13526 7926
Net Income 7896 8007 10869 2966

ZYDU Balance Sheet

Quick Ratio MRQ 1.25
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.02%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 258794 257564
Total Liabilities 49385 60681
Total Equity 209409 209409 196883 196883

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM 37.27
Revenue/Share TTM 187.95
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ZYDU Price Commentary

Write your thoughts about Zydus Lifesciences Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Akshath Suvarna
Akshath Suvarna Jan 12, 2024 9:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great buy ,best time to enter
Irfan ali
Irfan ali Dec 16, 2023 10:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After 655 coming breakout target 695 to 710
Hardik Vora
Hardik Vora Mar 12, 2022 9:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What Is The Target For Next Week?
Kshetrapal Sahu
Kshetrapal Sahu Jan 25, 2022 21:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is ne bhut so ko barbaad kra benkelode share ne
Jay JinDaL
Jay JinDaL Jan 16, 2022 18:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
3rd class stock
SHIVA shiva
SHIVA shiva Jan 07, 2022 14:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Magic starts....
Paramjit Lamba
Paramjit Lamba Aug 25, 2021 3:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to fly in September and early October. BUY at dips, preferably between 500 or below to 550 levels to make 100 to 150 plus gains.
Javgal Kanth
Javgal Kanth Aug 25, 2021 3:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good
Javgal Kanth
Javgal Kanth Aug 24, 2021 23:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
As YoY revenue is up, possibility of more revenue growth due to covid vaccine approval may result in QoQ net profit uptrend shows good returns in medium term. Buy on every decline below 500 for good returns in long term.
sandeep sheregar
sandeep sheregar May 26, 2021 6:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it may reaches upper circuit in few days. vaccine related mou done with govt. best pharma stock in coming days
Pankaj Kumar
Pankaj Kumar May 25, 2021 7:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
make position for June 10% gain is coming
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email